Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors

Tomoko Iwata-Kajihara, Hidetoshi Sumimoto, Naoshi Kawamura, Ryo Ueda, Tomomi Takahashi, Hiroyuki Mizuguchi, Makoto Miyagishi, Kiyoshi Takeda, Yutaka Kawakami

Research output: Contribution to journalArticle

57 Citations (Scopus)

Fingerprint Dive into the research topics of 'Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors'. Together they form a unique fingerprint.

Medicine & Life Sciences